Argan stock climbed vigorously in early trading after the company released first-quarter fiscal 2027 results that surpassed market forecasts. The shares were up nearly 9.7% in morning trade following results posted after the prior session closed that materially surprised investors.
On the numbers, Argan reported earnings per share of $3.24, well ahead of the consensus estimate of $1.82 - a beat of 78%. The firm recorded record quarterly revenue of $291 million, roughly $42 million above analyst expectations and representing a 50% increase compared with the same quarter a year earlier. Net income more than doubled year-over-year to $46.1 million. On an adjusted basis, EBITDA came in at $56.4 million, producing a margin of 19.4% compared with 16.3% in the prior-year quarter.
Company leadership reinforced confidence in Argan's position during the post-report earnings call. CEO David Watson stated that Argan held approximately $974 million in cash and investments and carried no debt. The board expanded the existing share repurchase authorization from $150 million to $200 million and extended the repurchase program through January 2030.
Management also described the company’s project pipeline. Argan reported a backlog of $2.8 billion, composed predominantly of natural gas, renewable, and industrial projects. Executives said they are actively pursuing additional awards over the next 10 to 18 months.
Brokerage House Lake Street left its rating at Hold but raised its price target to $600 from $375, reflecting an improved earnings trajectory based on the company’s reported results.
The wider U.S. equity market did not provide support for Argan’s move. The S&P 500 fell 1.0%, the Dow Jones Industrial Average was down 0.2%, and the NASDAQ declined 1.7% during the session, with technology and growth names under pressure. Against that backdrop, AGX’s pronounced advance underlines how the earnings beat drove investor behavior: the stock reached a fresh 52-week intraday high of $778.13.
The scale of the company’s outperformance appears to have altered market perception swiftly. What began as an after-hours uptick of roughly 3.7% evolved into a robust intraday rally by morning trading, underpinned by the combination of a sizable earnings surprise, record revenue, a cash-rich, debt-free balance sheet, a growing project backlog, and an expanded buyback program.
Taken together, those elements presented investors with several tangible reasons to re-evaluate Argan’s valuation even as broader markets struggled. Sector peers did not report material developments during the same session, leaving Argan’s results as the primary catalyst for the share-price move.
Contextual note - The company’s reported figures, balance sheet position, backlog makeup, buyback changes, and the broker response are presented as disclosed by management and the reporting broker. When numerical or temporal detail is limited in the disclosures, the article reflects those original statements without expansion.